Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Polinsky, R. J.
Right arrow Articles by Weise, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Polinsky, R. J.
Right arrow Articles by Weise, V.
NEUROLOGY 1981;31:1
© 1981 American Academy of Neurology

Pharmacologic distinction of different orthostatic hypotension syndromes

Ronald J. Polinsky, M.D., Irwin J. Kopin, M.D., Michael H. Ebert, M.D. and Virginia Weise, B.S.

From the Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, MD.

We studied the pressor responses to vasoactive agents in patients with orthostatic hypotension. Greater-than-normal slopes of the stimulus-response curves in patients with multiple system atrophy (Shy-Drager syndrome) and idiopathic orthostatic hypotension (IOH) were consistent with deficient reflex modulation. Patients with IOH also had a shift to the left of the plasma norepinephrine-blood pressure curves, suggesting ‘denervation supersensitivity.’This was consistent with the deficient plasma norepinephrine response to tyramine in these patients. Patients in whom orthostatic hypotension is attended by tachycardia are subsensitive to administered catecholamines, and may suffer from deficient effector organ responsivity.

Address correspondence and reprint requests to Dr. Polinsky, Laboratory of Clinical Science, National Institute of Mental Health, Building 10,3S-231, 9000 Rockville Pike, Bethesda, MD 20205.

Accepted for publication April 7, 1980.




This article has been cited by other articles:


Home page
 CirculationHome page
D. S. Goldstein and Y. Sharabi
Neurogenic Orthostatic Hypotension: A Pathophysiological Approach
Circulation, January 6, 2009; 119(1): 139 - 146.
[Full Text] [PDF]

Home page
 CirculationHome page
J. Jordan, A. Lipp, J. Tank, C. Schroder, M. Stoffels, G. Franke, A. Diedrich, G. Arnold, D. S. Goldstein, A. M. Sharma, et al.
Catechol-O-Methyltransferase and Blood Pressure in Humans
Circulation, July 23, 2002; 106(4): 460 - 465.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
R. E. Shapiro, B. Winters, M. Hales, T. Barnett, D. A. Schwinn, N. Flavahan, and D. E. Berkowitz
Endogenous Circulating Sympatholytic Factor in Orthostatic Intolerance
Hypertension, October 1, 2000; 36(4): 553 - 560.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
S. Braune, M. Reinhardt, R. Schnitzer, A. Riedel, and C. H. Lucking
Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy
Neurology, September 1, 1999; 53(5): 1020 - 1020.
[Abstract] [Full Text]

Home page
 NeurologyHome page
E. K. St. Louis, E. F.M. Widjicks, and H. Li
Predicting neurologic deterioration in patients with cerebellar hematomas
Neurology, November 1, 1998; 51(5): 1364 - 1369.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
A. Lieberman, C. W. Olanow, K. Sethi, P. Swanson, C. H. Waters, S. Fahn, H. Hurtig, M. Yahr, and the Ropinirole Study Group*
A multicenter trial of ropinirole as adjunct treatment for Parkinson's disease
Neurology, October 1, 1998; 51(4): 1057 - 1062.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
S. Ono, K. Takahashi, K. Jinnai, F. Kanda, Y. Fukuoka, H. Kurisaki, S. Mitake, T. Inagaki, T. Yamano, N. Shimizu, et al.
Loss of catecholaminergic neurons in the medullary reticular formation in myotonic dystrophy
Neurology, October 1, 1998; 51(4): 1121 - 1124.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
S. A. Rudnicki, S. I. Harik, M. Dhodapkar, B. Barlogie, and D. Eidelberg
Nervous system dysfunction in Waldenstrom's macroglobulinemia: Response to treatment
Neurology, October 1, 1998; 51(4): 1210 - 1213.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
A. Ohnishi, T. Yamamoto, Y. Murai, Y. Ando, M. Ando, Y. Hoshii, and M. Ikeda
Denervation of eccrine glands in patients with familial amyloidotic polyneuropathy type I
Neurology, September 1, 1998; 51(3): 714 - 721.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
P. G. Jenner and M. F. Brin
Levodopa neurotoxicity: Experimental studies versus clinical relevance
Neurology, June 1, 1998; 50(6_Suppl_6): S39 - S43.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
G. Plazzi, P. Cortelli, P. Montagna, A. De Monte, R. Corsini, M. Contin, F. Provini, G. Pierangeli, and E. Lugaresi
REM sleep behaviour disorder differentiates pure autonomic failure from multiple system atrophy with autonomic failure
J. Neurol. Neurosurg. Psychiatry, May 1, 1998; 64(5): 683 - 685.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
Y. Agid
Levodopa: Is toxicity a myth?
Neurology, April 1, 1998; 50(4): 858 - 863.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
P. A. Silburn, G. A. Nicholson, B. T. Teh, I. P. Blair, J. D. Pollard, P. J. Nolan, C. Larsson, and R. S. Boyle
Charcot-Marie-Tooth disease and Noonan syndrome with giant proximal nerve hypertrophy
Neurology, April 1, 1998; 50(4): 1067 - 1073.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
Management of Parkinson's disease
Neurology, March 1, 1998; 50(3_Suppl_3): S2 - S57.
[Full Text] [PDF]

Home page
 NeurologyHome page
H. Miyajima, J. Adachi, Y. Tatsuno, Y. Takahashi, M. Fujimoto, E. Kaneko, and J. D. Gitlin
Increased very long-chain fatty acids in erythrocyte membranes of patients with aceruloplasminemia
Neurology, January 1, 1998; 50(1): 130 - 136.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
U. Bonuccelli, R. Ceravolo, S. Salvetti, C. D'Avino, P. Del Dotto, G. Rossi, and L. Murri
Clozapine in Parkinson's disease tremor: Effects of acute and chronic administration
Neurology, December 1, 1997; 49(6): 1587 - 1590.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
L. H. Lu, A. M. Barrett, R. L. Schwartz, J. E. Cibula, R. L. Gilmore, B. M. Uthman, and K. M. Heilman
Anosognosia and confabulation during the Wada test
Neurology, November 1, 1997; 49(5): 1316 - 1322.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. P. Blaber, R. L. Bondar, F. Stein, P. T. Dunphy, P. Moradshahi, M. S. Kassam, and R. Freeman
Complexity of middle cerebral artery blood flow velocity: effects of tilt and autonomic failure
Am J Physiol Heart Circ Physiol, November 1, 1997; 273(5): H2209 - H2216.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
J. Shannon, J. Jordan, F. Costa, R. M. Robertson, and I. Biaggioni
The Hypertension of Autonomic Failure and Its Treatment
Hypertension, November 1, 1997; 30(5): 1062 - 1067.
[Abstract] [Full Text]

Home page
 NeurologyHome page
R. Massa, G. Sancesario, and G. Bernardi
Muscle phosphofructokinase deficiency
Neurology, September 1, 1997; 49(3): 899 - 899.
[Full Text] [PDF]

Home page
 NeurologyHome page
K. Sivakumar, O. Vasconcelos, L. Goldfarb, and M. C. Dalakas
Muscle phosphofructokinase deficiency
Neurology, September 1, 1997; 49(3): 899 - 899.
[Full Text] [PDF]

Home page
 NeurologyHome page
E. Granieri and I. Casetta
Common childhood and adolescent infections and multiple sclerosis
Neurology, August 1, 1997; 49(2_Suppl_2): S42 - S54.
[Full Text] [PDF]

Home page
 NEJMHome page
I. J. Schatz, P. Low, R. J. Polinsky, D. S. Goldstein, G. Eisenhofer, and I. J. Kopin
Disorders of the Autonomic Nervous System
N. Engl. J. Med., July 24, 1997; 337(4): 278 - 280.
[Full Text]

Home page
 NeurologyHome page
I. Litvan, Y. Agid, N. Sastrj, J. Jankovic, G. K. Wenning, C. G. Goetz, M. Verny, J. P. Brandel, K. Jellinger, K. R. Chaudhuri, et al.
What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study
Neurology, July 1, 1997; 49(1): 62 - 69.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. B. Stern
Contemporary approaches to the pharmacotherapeutic management of Parkinson's disease: An overview
Neurology, July 1, 1997; 49(1_Suppl_1): S2 - S9.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
C. W. Olanow
Attempts to obtain neuroprotection in Parkinson's disease
Neurology, July 1, 1997; 49(1_Suppl_1): S26 - S33.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
R. L. Watts
The role of dopamine agonists in early Parkinson's disease
Neurology, July 1, 1997; 49(1_Suppl_1): S34 - S48.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. Jankovic and J. Beach
Long-term effects of tetrabenazine in hyperkinetic movement disorders
Neurology, February 1, 1997; 48(2): 358 - 362.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. Gardnerova, B. Eymard, E. Morel, M. Faltin, J. Zajac, O. Sadovsky, P. Tripon, M. Domergue, B. Vernet-der Garabedian, and J. F. Bach
The Fetal/Adult Acetylcholine Receptor Antibody Ratio in Mothers with Myasthenia Gravis as a Marker for Transfer of the Disease to the Newborn
Neurology, January 1, 1997; 48(1): 50 - 54.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
Y. Tanaka, Y. Miyazawa, F. Akaoka, and T. Yamada
Amnesia Following Damage to the Mammillary Bodies
Neurology, January 1, 1997; 48(1): 160 - 165.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
A. Beydoun, J. C. Sackellares, and V. Shu
Safety and Efficacy of Divalproex Sodium Monotherapy in Partial Epilepsy: A Double-blind, Concentration-response Design Clinical Trial
Neurology, January 1, 1997; 48(1): 182 - 188.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
A. Agathonikou, M. Koutroumanidis, and C. P. Panayiotopoulos
Fixation-off-sensitive Epilepsy with Absences and Absence Status: Video-EEG Documentation
Neurology, January 1, 1997; 48(1): 231 - 234.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
P. Jenner and C. W. Olanow
Oxidative stress and the pathogenesis of Parkinson's disease
Neurology, December 1, 1996; 47(6_Suppl_3): 161S - 170S.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
S. Fahn
Is levodopa toxic?
Neurology, December 1, 1996; 47(6_Suppl_3): 184S - 195S.
[Full Text] [PDF]

Home page
 NeurologyHome page
V. V. Myllyla, K. Sotaniemi, O. Maki-Ikola, U. K. Rinne, and E. H. Heinonen
Role of selegiline in combination therapy of Parkinson's disease
Neurology, December 1, 1996; 47(6_Suppl_3): 200S - 209S.
[Full Text] [PDF]

Home page
 NeurologyHome page
C. W. Olanow
Selegiline: Current perspectives on issues related to neuroprotection and mortality
Neurology, December 1, 1996; 47(6_Suppl_3): 210S - 216S.
[Full Text] [PDF]

Home page
 NeurologyHome page
M. F. Mendez, M. Cherrier, K. M. Perryman, N. Pachana, B. L. Miller, and J. L. Cummings
Frontotemporal dementia versus Alzheimer's disease: Differential cognitive features
Neurology, November 1, 1996; 47(5): 1189 - 1194.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
S. E. Piwinski, Z. Windrow, and S. Newman
Periodic paralysis
Neurology, August 1, 1996; 47(2): 610 - 610.
[Full Text] [PDF]

Home page
 NeurologyHome page
I. Kantola and L. Tarssanen
Reply from the Authors: Periodic paralysis
Neurology, August 1, 1996; 47(2): 610 - 610.
[Full Text] [PDF]

Home page
 HypertensionHome page
N. L. Benowitz, S. Zevin, S. Carlsen, J. Wright, M. Schambelan, and M. Cheitlin
Orthostatic Hypertension Due to Vascular Adrenergic Hypersensitivity
Hypertension, July 1, 1996; 28(1): 42 - 46.
[Abstract] [Full Text]

Home page
 NeurologyHome page
D. F. Benson, A. Djenderedjian, B. L. Miller, N. A. Pachana, L. Chang, L. Itti, and I. Mena
Neural basis of confabulation
Neurology, May 1, 1996; 46(5): 1239 - 1239.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
K. Sivakumar, O. Vasconcelos, L. Goldfarb, and M. C. Dalakas
Late-onset muscle weakness in partial phosphofructokinase deficiency: A unique myopathy with vacuoles, abnormal mitochondria, and absence of the common exon 5/intron 5 junction point mutation
Neurology, May 1, 1996; 46(5): 1337 - 1337.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
B. M. van Geel, J. H.T.M. Koelman, P. G. Barth, and B. W. Ongerboer de Visser
Peripheral nerve abnormalities in adrenomyeloneuropathy: A clinical and electrodiagnostic study
Neurology, January 1, 1996; 46(1): 112 - 118.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
S. Ono, F. Kanda, K. Takahashi, Y. Fukuoka, K. Jinnai, H. Kurisaki, S. Mitake, T. Inagaki, and K. Nagao
Neuronal loss in the medullary reticular formation in myotonic dystrophy: A clinicopathological study
Neurology, January 1, 1996; 46(1): 228 - 231.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. J. Berg and L. S. Williams
The transient syndrome of headache with neurologic deficits and CSF lymphocytosis
Neurology, September 1, 1995; 45(9): 1648 - 1654.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
T. Yokota, M. Hayashi, F. Hirashima, M. Mitani, H. Tanabe, and H. Tsukagoshi
Dysautonomia With Acute Sensory Motor Neuropathy: A New Classification of Acute Autonomic Neuropathy
Arch Neurol, October 1, 1994; 51(10): 1022 - 1031.
[Abstract] [PDF]

Home page
 ANGIOLOGYHome page
C. Asato, H. Muratani, T. Touma, N. Kawazoe, Y. Kimura, S. Takishita, and K. Fukiyama
Renin Responses in Patients with Orthostatic Hypotension: Case Reports
Angiology, July 1, 1993; 44(7): 587 - 592.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
L. E. Nee, R. T. Brown, and R. J. Polinsky
HLA in Autonomic Failure
Arch Neurol, July 1, 1989; 46(7): 758 - 759.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by AAN Enterprises, Inc.